跳至主要内容
临床试验/NCT06408571
NCT06408571Enrolling By Invitation不适用

Study on the Pathogenesis of Retinal Vascular Diseases Based on Body Fluid Metabolomics

Zhongnan Hospital1 个研究点 分布在 1 个国家目标入组 3,900 人开始时间: 2023年9月7日最近更新:
适应症

试验速览

阶段
不适用
状态
Enrolling By Invitation
发起方
入组人数
3,900
试验地点
1
主要终点
Screening of prognostic markers and model validation

研究概览

简要总结

Through the analysis of metabolites in body fluids (intraocular fluid, plasma) of patients with retinal vascular diseases (retinal vein occlusion, diabetic retinopathy), the possible pathogenesis of retinal vein occlusion was explored.

详细描述

  1. Clinical data of patients with RVO and DR Were retrospectively studied to analyze their pathogenesis. 2. Metabolomic studies were conducted on body fluids (intraocular fluid and peripheral blood) of patients with RVO and DR And control group to find out the differences and find new targets for the prevention and treatment of RVO and DR.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥18 years old
  • Confirmed diagnosis of retinal vein obstruction and diabetic retinopathy through ophthalmic specialist examination

排除标准

  • Severe systemic diseases
  • Pregnant and lactating patients

结局指标

主要结局

Screening of prognostic markers and model validation

时间窗: 1/12/2024-30/12/2024

1. Surface markers and key molecules related to the study of diseases were screened out, and a biomarker model for assessing disease prognosis was established. 2. Candidate differential molecules were screened through a training cohort, a Cox regression model was constructed, and the prognostic value of the model was verified in the test cohort.

次要结局

未报告次要终点

研究者

发起方
Zhongnan Hospital
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验